Navigation Links
Prometic provides information for its Annual and Special Meeting of Shareholders
Date:5/1/2008

MONTREAL, May 1 /PRNewswire-FirstCall/ - ProMetic Life Sciences Inc. ("ProMetic") (TSX:PLI) will host its Annual and Special Meeting of Shareholders on Wednesday, May 7, 2008 at 10:30 a.m. (EDT). The Annual and Special Meeting of Shareholders ("Meeting") will be held at the Montreal Museum of Fine Arts located at 1379 Sherbrooke Street West in Montreal. Points to be covered are:

- Items on the Meeting's agenda as per the Management Information

Circular

- Corporate Presentations

- MacoPharma presents update on launch of P-Capt(R) prion capture

filter

- Protein Technologies business update

- Anemia drugs program update - PBI-1402 and analogues

- Corporate strategy to build shareholder value

Following these presentations shareholders and guests will have the opportunity of viewing displays on ProMetic's various products, as well as meeting members of management and scientists who will be gathered for the occasion.

For those who are unable to attend in person, the Company will offer a live audio webcast through ProMetic's website at http://www.prometic.com. A replay of the webcast will be available following the meeting on ProMetic's website.

About ProMetic Life Sciences Inc.

ProMetic Life Sciences Inc. ("ProMetic") (http://www.prometic.com) is a biopharmaceutical company specialized in the research, development, manufacture and marketing of a variety of commercial applications derived from its proprietary Mimetic Ligand(TM) technology. This technology is used in large-scale purification of biologics and the elimination of pathogens. ProMetic is also active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on re
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ProMetic presents preclinical data for prostate and pancreatic cancer at the AACR Meeting
2. ProMetic to obtain controlling stake in Pathogen Removal and Diagnostic Technologies Inc.
3. Prometic to present at the American Chemical Society
4. ProMetic and Sartorius Stedim Biotech collaborate on technology transfer deals in Asia
5. ProMetic reports continued positive data in PBI-1402 phase II trial in chemotherapy-induced anemia
6. ProMetic announces signature of definitive license agreement with Kedrion for two hyperimmune products
7. ProMetic provides business update - Over $35 million worth of business secured in January
8. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
9. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
10. AEterna Zentaris Partner, Spectrum, Provides Update on Ozarelix in Benign Prostatic Hyperplasia
11. Genzyme Provides Update on Myozyme(R) Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... March 5, 2015   HX360 today announced ... the HX360 Innovation Challenge competition. These companies, ... to be chosen as one of four finalists to ... health system executives and venture capitalists during the Innovation ... takes place at the 2015 HIMSS Annual Conference & ...
(Date:3/5/2015)... Bi-Biomics today announced a discovery ... additive. The improvement in histological quality provided the ... in all daughter cells. , After processing with ... analyzed at 1000-1600x using light microscopy. Phylogenetic ... all daughter cells displayed predominant binary features --- ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... of the "Mature Biotech Outlook 2015: New Therapy ... their offering. All biotech companies - ... (CELG), in past year, have given a positive return ... companies have been able to select therapy/niche indication where ...
(Date:3/5/2015)... 05, 2015 RMI ... chronic orthopedic conditions such as meniscal tears, ACL ... and joint pain due to degenerative conditions like ... orthopedic surgeries to promote better post-surgical outcomes. , ... nearly pain-free bone marrow harvesting with two complimentary ...
Breaking Biology Technology:HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 2HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 3HX360 Announces Sixteen Innovation Challenge Semi-finalists Competing To Deliver Solutions That Improve The Patient Experience 4Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 2Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 2Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 3Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 4Riordan-McKenna Institute of Regenerative Orthopedics and Stem Cell Therapy Announces Open House in Southlake, Texas on Friday, March 6th from 5:30 pm to 7:30 pm. 5
... Market Opportunities for the Company,s Medical ... ... ), a biodefense company developing medical countermeasures,against biological and chemical threats, ... special UK government advisor., Lord Moonie will assist PharmAthene in ...
... China, Aug. 11 /Xinhua-PRNewswire-FirstCall/ -- Huifeng,Bio-Pharmaceutical Technology, Inc ... of plant extracts and pharmaceutical raw materials,for use ... it has signed a major supply agreement with ... Under the terms of the agreement Huifeng ...
... First Commercial Imaging Lab to Offer Quantitative Coronary Angiographic ... ... 11 ICON plc (NASDAQ: ICLR;,ISIN:IE0005711209), a global provider ... device industries, today,announced that its Medical Imaging division has ...
Cached Biology Technology:Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene 2Lord Lewis Moonie to Serve as Special UK Government Advisor to PharmAthene 3Huifeng Bio-Pharmaceutical (HFGB) Announces USD $1.1 Million Supply Agreement with DNP International Co. Inc. 2ICON Medical Imaging Launches New Service to Boost Reliability of Cardiology Studies 2
(Date:2/23/2015)... NXT-ID, Inc. (NASDAQ: NXTD ... company focused on the growing mobile commerce market, announced ... DISTRIBUTED VOICE DIRECTED PAYMENT METHOD AND SYSTEM. ... groundbreaking payment method. Payment accounts may be selected via ... accessed if both the speech (the word associated with ...
(Date:2/13/2015)... TAIPEI , Feb. 13, 2015 ... service company that aims to transform cancer genomic ... announced that the company has raised US$ 8 million ... Based in Taipei, Taiwan ... tests, ACTDrug™, ACTOnco™. With the aim to implement ...
(Date:2/11/2015)... According to a ... Product (Cards and Readers, Biometrics, Controllers, Management Software), ... Healthcare, Education) and By Geography - Global Forecast and Analysis to ... Control Market is expected to reach $10.4 ... of 10.6% between 2014 and 2020. ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3ACT Genomics Raises $8 Million in its First Private Funding Round 2Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4
... Lab has published recent findings that reveal some of the factors ... The paper, Stem Cell Aging is Controlled both Intrinsically ... 11 issue of Cell Stem Cell. Lei Pan, Predoctoral Researcher, and ... authors, respectively. It is ...
... base operations have left the U.S. Department of Defense (DOD) ... with highly toxic substances. University of Tennessee Research Professor ... awarded $1.3 million over three years to find the best ... keeping costs to a minimum. Parker is ...
... by Kevin Pope of Geo Eco Arc Research and ... the migration of anatomically modern humans out of Africa ... (BP). The comprehensive review of human genetic, ... the hypothesis, originally based largely on genetic evidence, that ...
Cached Biology News:Stowers Institute's Xie Lab demonstrates dual intrinsic and extrinsic control of stem cell aging 2UT researcher earns $1.3M grant to study toxic cleanup at DOD sites 2UT researcher earns $1.3M grant to study toxic cleanup at DOD sites 3Environmental setting of human migrations in the circum-Pacific Region 2
... Spin Kit is an advanced system for isolating DNA ... can be used directly for any downstream application. ... ready to use in 56 minutes Low melting ... TAE and TBE gels No specialised equipment required ...
... The GenElute™ Minus EtBr Spin Columns provide a ... bromide (EtBr)-free DNA (100 bp to 10 kb) ... The DNA band is excised from an agarose ... within the base of the column are a ...
... The Ultra Silica Bead Kit has been designed ... gels and solutions. Features Ultra ... minutes Uniform silica beads are easy to resuspend ... DNA Highly pure DNA (suitable for PCR) ...
... DNA Kit enables efficient extraction of DNA fragments from ... agarose gels. The procedure uses GelMelt solution to dissolve ... to a silica membrane in a spin column format. ... in low-salt buffer. Each spin column can bind up ...
Biology Products: